An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Exclusion Criteria

• •Participants with Crohn's Disease (CD), indeterminate colitis
• •Current diagnosis of Ulcerative Proctitis
• •Participants with surgical bowel resection within the past 3 months prior to Baseline, or a history of \>3 bowel resections
• •Prior or current high-grade gastrointestinal (GI) dysplasia
• •Participants on treatment with but not on stable doses of conventional therapies prior to baseline
• •Participants with prohibited medications or therapies prior to baseline
• •Participants with previous exposure to anti-TL1A investigational therapy The above information is not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.